vs

Side-by-side financial comparison of Madison Square Garden Sports Corp. (MSGS) and TANDEM DIABETES CARE INC (TNDM). Click either name above to swap in a different company.

Madison Square Garden Sports Corp. is the larger business by last-quarter revenue ($403.4M vs $290.4M, roughly 1.4× TANDEM DIABETES CARE INC). Madison Square Garden Sports Corp. runs the higher net margin — 2.0% vs -0.2%, a 2.2% gap on every dollar of revenue. On growth, Madison Square Garden Sports Corp. posted the faster year-over-year revenue change (12.8% vs 2.7%). Madison Square Garden Sports Corp. produced more free cash flow last quarter ($31.6M vs $3.1M). Over the past eight quarters, TANDEM DIABETES CARE INC's revenue compounded faster (23.1% CAGR vs -3.1%).

Madison Square Garden Sports Corp. is an American sports holding company based in New York City.

Tandem Diabetes Care, Inc. is an American medical device manufacturer based in San Diego, California. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy.

MSGS vs TNDM — Head-to-Head

Bigger by revenue
MSGS
MSGS
1.4× larger
MSGS
$403.4M
$290.4M
TNDM
Growing faster (revenue YoY)
MSGS
MSGS
+10.0% gap
MSGS
12.8%
2.7%
TNDM
Higher net margin
MSGS
MSGS
2.2% more per $
MSGS
2.0%
-0.2%
TNDM
More free cash flow
MSGS
MSGS
$28.5M more FCF
MSGS
$31.6M
$3.1M
TNDM
Faster 2-yr revenue CAGR
TNDM
TNDM
Annualised
TNDM
23.1%
-3.1%
MSGS

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
MSGS
MSGS
TNDM
TNDM
Revenue
$403.4M
$290.4M
Net Profit
$8.2M
$-589.0K
Gross Margin
57.7%
Operating Margin
5.5%
2.9%
Net Margin
2.0%
-0.2%
Revenue YoY
12.8%
2.7%
Net Profit YoY
641.9%
-178.0%
EPS (diluted)
$0.34
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSGS
MSGS
TNDM
TNDM
Q4 25
$403.4M
$290.4M
Q3 25
$39.5M
$249.3M
Q2 25
$204.0M
$240.7M
Q1 25
$424.2M
$234.4M
Q4 24
$357.8M
$282.6M
Q3 24
$53.3M
$244.0M
Q2 24
$227.3M
$221.9M
Q1 24
$430.0M
$191.7M
Net Profit
MSGS
MSGS
TNDM
TNDM
Q4 25
$8.2M
$-589.0K
Q3 25
$-8.8M
$-21.2M
Q2 25
$-1.8M
$-52.4M
Q1 25
$-14.2M
$-130.6M
Q4 24
$1.1M
$755.0K
Q3 24
$-7.5M
$-23.3M
Q2 24
$25.5M
$-30.8M
Q1 24
$37.9M
$-42.7M
Gross Margin
MSGS
MSGS
TNDM
TNDM
Q4 25
57.7%
Q3 25
53.9%
Q2 25
52.3%
Q1 25
50.5%
Q4 24
55.7%
Q3 24
51.1%
Q2 24
50.8%
Q1 24
49.4%
Operating Margin
MSGS
MSGS
TNDM
TNDM
Q4 25
5.5%
2.9%
Q3 25
-69.5%
-9.2%
Q2 25
-11.1%
-21.5%
Q1 25
7.6%
-51.6%
Q4 24
3.7%
-0.2%
Q3 24
-15.5%
-10.7%
Q2 24
23.0%
-13.9%
Q1 24
18.5%
-21.7%
Net Margin
MSGS
MSGS
TNDM
TNDM
Q4 25
2.0%
-0.2%
Q3 25
-22.3%
-8.5%
Q2 25
-0.9%
-21.8%
Q1 25
-3.4%
-55.7%
Q4 24
0.3%
0.3%
Q3 24
-14.1%
-9.5%
Q2 24
11.2%
-13.9%
Q1 24
8.8%
-22.3%
EPS (diluted)
MSGS
MSGS
TNDM
TNDM
Q4 25
$0.34
$0.02
Q3 25
$-0.37
$-0.31
Q2 25
$-0.08
$-0.78
Q1 25
$-0.59
$-1.97
Q4 24
$0.05
$0.00
Q3 24
$-0.31
$-0.35
Q2 24
$1.07
$-0.47
Q1 24
$1.57
$-0.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSGS
MSGS
TNDM
TNDM
Cash + ST InvestmentsLiquidity on hand
$81.3M
$292.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$-282.1M
$155.2M
Total Assets
$1.5B
$881.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSGS
MSGS
TNDM
TNDM
Q4 25
$81.3M
$292.7M
Q3 25
$48.6M
$319.1M
Q2 25
$144.6M
$315.4M
Q1 25
$96.5M
$368.6M
Q4 24
$107.8M
$438.3M
Q3 24
$52.3M
$473.3M
Q2 24
$89.1M
$452.4M
Q1 24
$40.0M
$467.8M
Stockholders' Equity
MSGS
MSGS
TNDM
TNDM
Q4 25
$-282.1M
$155.2M
Q3 25
$-294.2M
$133.0M
Q2 25
$-281.4M
$133.3M
Q1 25
$-283.4M
$155.3M
Q4 24
$-273.1M
$263.1M
Q3 24
$-277.5M
$237.7M
Q2 24
$-266.3M
$233.9M
Q1 24
$-294.0M
$243.1M
Total Assets
MSGS
MSGS
TNDM
TNDM
Q4 25
$1.5B
$881.1M
Q3 25
$1.5B
$874.7M
Q2 25
$1.5B
$875.7M
Q1 25
$1.5B
$922.1M
Q4 24
$1.4B
$967.7M
Q3 24
$1.4B
$957.7M
Q2 24
$1.3B
$937.5M
Q1 24
$1.4B
$941.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSGS
MSGS
TNDM
TNDM
Operating Cash FlowLast quarter
$32.4M
$9.8M
Free Cash FlowOCF − Capex
$31.6M
$3.1M
FCF MarginFCF / Revenue
7.8%
1.1%
Capex IntensityCapex / Revenue
0.2%
2.3%
Cash ConversionOCF / Net Profit
3.94×
TTM Free Cash FlowTrailing 4 quarters
$-480.0K
$-29.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSGS
MSGS
TNDM
TNDM
Q4 25
$32.4M
$9.8M
Q3 25
$-85.0M
$8.3M
Q2 25
$49.7M
$-9.5M
Q1 25
$6.3M
$-18.3M
Q4 24
$61.8M
$10.7M
Q3 24
$-26.2M
$26.8M
Q2 24
$108.4M
$-5.3M
Q1 24
$4.0M
$-8.0M
Free Cash Flow
MSGS
MSGS
TNDM
TNDM
Q4 25
$31.6M
$3.1M
Q3 25
$-85.3M
$4.2M
Q2 25
$49.4M
$-15.7M
Q1 25
$3.9M
$-21.2M
Q4 24
$61.2M
$7.6M
Q3 24
$-26.5M
$21.5M
Q2 24
$108.0M
$-11.7M
Q1 24
$3.9M
$-12.5M
FCF Margin
MSGS
MSGS
TNDM
TNDM
Q4 25
7.8%
1.1%
Q3 25
-216.3%
1.7%
Q2 25
24.2%
-6.5%
Q1 25
0.9%
-9.1%
Q4 24
17.1%
2.7%
Q3 24
-49.7%
8.8%
Q2 24
47.5%
-5.3%
Q1 24
0.9%
-6.5%
Capex Intensity
MSGS
MSGS
TNDM
TNDM
Q4 25
0.2%
2.3%
Q3 25
0.9%
1.6%
Q2 25
0.2%
2.6%
Q1 25
0.6%
1.3%
Q4 24
0.1%
1.1%
Q3 24
0.7%
2.1%
Q2 24
0.2%
2.9%
Q1 24
0.0%
2.3%
Cash Conversion
MSGS
MSGS
TNDM
TNDM
Q4 25
3.94×
Q3 25
Q2 25
Q1 25
Q4 24
55.61×
14.19×
Q3 24
Q2 24
4.25×
Q1 24
0.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MSGS
MSGS

Event Related$167.2M41%
Media Rights$122.3M30%
Sponsorship Signage And Suite Licenses$98.5M24%
League Distribution$15.4M4%

TNDM
TNDM

Supplies And Other$150.3M52%
Pump$140.1M48%

Related Comparisons